XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 13,662 $ 10,653
Trade accounts receivable, net of allowance for doubtful accounts of $315 and $317, respectively 19,156 21,054
Inventories, net 27,856 28,193
Prepaid expenses and other current assets 2,846 4,596
Total current assets 63,520 64,496
Property, plant and equipment, net 22,946 22,850
Goodwill 27,061 27,018
Other intangible assets, net 9,077 9,209
Deferred income taxes, net 11,652 11,836
Other noncurrent assets 2,134 2,292
Total Assets 136,390 137,701
Current Liabilities:    
Accounts payable 10,141 10,839
Current portion of long-term debt, net 993 1,361
Accrued compensation and related benefits 1,404 1,748
Accrued expenses and other current liabilities 4,097 4,758
Total current liabilities 16,635 18,706
Deferred income taxes 504 515
Other noncurrent liabilities 1,390 1,557
Total liabilities 18,529 20,778
Commitments and contingencies (Note 8)
Shareholders’ equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,416,511 shares at March 31, 2021 and 20,373,519 shares at December 31, 2020; outstanding – 15,994,606 shares at March 31, 2021 and 15,959,984 shares at December 31, 2020 2,042 2,037
Capital in excess of par value 185,674 185,464
Accumulated deficit (46,927) (47,598)
Accumulated other comprehensive loss (1,679) (1,782)
Treasury stock - at cost; 4,421,905 shares at March 31, 2021 and 4,413,535 shares at December 31, 2020 (21,380) (21,321)
Total Ultralife Corporation equity 117,730 116,800
Non-controlling interest 131 123
Total shareholders’ equity 117,861 116,923
Total liabilities and shareholders’ equity $ 136,390 $ 137,701